Cadila Healthcare Ltd


BSE: 532321 | NSE: CADILAHC | ISIN: INE010B01019 
Market Cap: [Rs.Cr.] 15,285 | Face Value: [Rs.] 5
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

 Discuss this stock

Board Meet

10-May-12 
Cadila Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 10, 2012 inter alia, to consider Audited Financial Results for the year ended March 31, 2012 and to recommend the dividend on equity shares for the year ended March 31, 2012. Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 10, 2012, inter alia, has recommended a dividend of Rs. 7.50/- [@150%] per equity share on 204,748,520 equity shares of Rs. 5/- each for the financial year ended on March 31, 2012. (As Per BSE Announcement Website Dated on 10/05/2012) 
07-Feb-12 
Cadila Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 07, 2012, inter alia, to consider unaudited financial results for the quarter/nine months ended on December 31, 2011 (Q3). 
10-Nov-11 
Cadila Healthcare Ltd has informed BSE that a meeting of the Board of the Directors of the Company will be held on November 10, 2011, inter alia, to consider unaudited financial results for the quarter/half-year ended on September 30, 2011 (Q2). 
19-Jul-11 
Cadila Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 19, 2011, inter alia, to consider unaudited financial results for the quarter ended on June 30, 2011. 
06-May-11 
Cadila Healthcare Ltd has informed BSE that a meeting of the Board of the Directors of the Company will be held on May 06, 2011, inter alia, to consider audited financial results for the year ended on March 31, 2011 and to recommend the dividend on equity shares for the year ended March 31, 2011. Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 06, 2011, inter alia, have recommended a Dividend of Rs. 6.25/- (@ 125%) per equity share on 204,748,520 equity shares of Rs. 5/- each for the financial year ended March 31, 2011. Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 06, 2011, inter alia, appointed Mr. Nitin Raojibhai Desai as an Additional Director. He is a Non-Executive and Independent Director on the Board w.e.f. May 06, 2011. (As Per BSE Announcement Website dated on 06.05.2011) 

AGM

06-Aug-12
Cadila Healthcare Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 30, 2012 to August 06, 2012 (both days inclusive) for the purpose of Payment of Dividend & 17th Annual General Meeting (AGM) of the Company to be held on August 06, 2012. The Dividend, if declared by the members will be paid to the members on August 11, 2012. 
19-Jul-11
Cadila Healthcare Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 11, 2011 to July 19, 2011 (both days inclusive) for the purpose of Payment of Dividend & 16th Annual General Meeting (AGM) of the Company to be held on July 19, 2011. Cadila Healthcare Ltd has informed BSE that the Company shall make the payment of dividend of Rs. 6.25 (125%) on 20,47,48,520 equity shares of Rs. 5/- each on July 25, 2011 subject to the approval of the same by the shareholders at the ensuing 16th Annual General Meeting scheduled to be held on July 19, 2011. (As Per BSE Announcement Dated on 16.05.2011) Cadila Healthcare Ltd has informed BSE that 16th Annual General Meeting (AGM) of the Company was held on July 19, 2011.inter alia, have accorded to the following: 1. Adoption of the Audited Balance Sheet as at March 31, 2011 and Profit and Loss Account of the Company for the year ended on that date and the Reports of the Auditors and Directors thereon together with Consolidated Balance Sheet as at March 31, 2011 and Profit and Loss Account for the year ended on that date and the report of the auditors thereon. 2. Declaration of the dividend of Rs. 6.25/- @ 125 % per equity share, aggregating to Rs. 1,279,678,250/- on 20,47,48,520 equity shares of Rs. 5/- each, and that the dividend shall be made payable to those shareholders of the Company whose names appear in the Register of Members of the Company on July 19, 2011 in respect of members holding shares in physical form and as per the list of beneficiaries downloaded from the depositories as on book closure date for the members holding shares in electronic form. 3. Re-appointment of Mr. Humayun Dhanrajgir, as Director of the Company, liable to retire by rotation. 4. Appointment of M/s Mukesh M. Shah & Co., Chartered Accountants, Ahmedabad, as Statutory Auditors of the Company from the conclusion of this Annual General Meeting until the conclusion of the next Annual General Meeting, on remuneration, terms & conditions. 5. Re-appointment of Mr. Pankaj R. Patel as Managing Director of the Company for a period of five years with effect from September 01, 2011, on remuneration, terms & conditions. 6. Appointment of Mr. Nitin Raojibhai Desai as a Director of the Company, liable to retire by rotation. (As Per BSE Announcement Dated on 29.07.2011) 
27-Jul-10
Cadila Healthcare Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 19, 2010 to July 24, 2010 (both days inclusive) for the purpose of 15th Annual General Meeting (AGM) of the Company to be held on July 27, 2010. Cadila Healthcare Ltd has informed BSE that the shareholders at the 15th Annual General Meeting (AGM) of the Company held on July 27, 2010, inter alia, have accorded to the following: 1. Adoption of Audited Balance Sheet as at March 31, 2010 and Profit and Loss Account of the Company for the year ended on that date and the Report of the Auditors and Directors, thereon together with Consolidated Balance Sheet as at March 31, 2010 and consolidated Profit and Account for the year ended or that date and the reports of the auditors thereon. 2. Declaration of dividend of Rs. 5.00/- (@ 100%) per equity share, on equity shares of Rs 5/- each. 3. Re-appointment of Mr. Apurva S Diwanji & Mr. Mukesh M Patel as Directors of the Company, liable to retire by rotation. 4 Appointment of M/s. Mukesh M Shah & Co. Chartered Accountants, Ahmedabad, as a Statutory Auditors of the Company from the conclusion of this Annual General Meeting until the conclusion of the next Annual General Meeting of the Company, on remuneration, terms & conditions. 5. For payment of sitting fees to the non-executive Directors for attending each of the meeting of the Board and the Committees of Board of Directors, as may be decided by the Board of Directors w.e.f. October 01, 2009, on necessary terms & conditions. 6. Revision of remuneration of Dr. Sharvil P. Patel, Deputy Managing Director with effect from April 01, 2010 for the remaining tenure of his appointment, up to 5% of the net profits of the Company compute in the manner laid down in sections 349 and 350 of the Companies Act, 1956 (the Act) during any financial year or such other limits as may be prescribed by Central Government. (As Per BSE Announcement Dated on 03.08.2010) 
29-Jul-09
Cadila Healthcare Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 20, 2009 to July 29, 2009 (both days inclusive) for the purpose of payment of dividend & 14th Annual General Meeting (AGM) of the Company to be held on July 29, 2009. Cadila Healthcare Ltd has informed BSE that Mr. Homi K Bilpodiwala, director of the Company who was liable to retire by rotation at the 14th Annual General Meeting of the Company held July 29, 2009 had not offered himself for re-appointment. In view of the same, Mr. Homi K Bilpodiwala ceased to be a director of the Company w.e.f July 29, 2009 after conclusion of the Annual General Meeting. (As Per BSE Announcement Dated on 29/07/2009) Cadila Healthcare Ltd has informed BSE that the shareholders at the 14th Annual General Meeting (AGM) of the Company held on July 29, 2009, inter alia, have accorded to the following: 1. Adoption of Audited Balance Sheet as at March 31, 2009 and Profit and Loss Account of the Company for the year ended on that date and the Report of the Auditors and Directors, thereon together with Consolidated Balance Sheet as at March 31, 2009 and consolidated Profit and Account for the year ended or that date and the reports of the auditors thereon. 2. Declaration of dividend of Rs 4.50/- (@ 90%) per equity share, on equity shares of Rs 5/- each. 3. Not to fill the vacancy caused by the retirement of Mr. H K Bilpodiwala, Director of the Company, who retires by rotation at this Annual General Meeting of the Company and who has not offered himself for re-appointment. 4. Re-appointment Mr. Dhanrajgir, as Director of the Company 5. Appointment of M/s. Mukesh M Shah & Co. Chartered Accountants, Ahmedabad, as a Statutory Auditors of the Company from the conclusion of this Annual General Meeting until the conclusion of the next Annual General Meeting of the Company, on remuneration, terms & conditions. (As Per BSE Announcement Website dated on 13.08.2009) 
29-Jul-08
Cadila Healthcare Limited has informed the Exchange that the Register of Members in respect of Equity Shares of the Company shall remain close from July 14, 2008 to July 26, 2008 (both days inclusive) to determine the entitlement of membership of the Company for the payment of dividend as may be declared by the members at the Annual General Meeting of the Company to be held on July 29, 2008 for the year ended March 31, 2008. (As Per NSE Bulletin Dated on 29.04.2008) Cadila Healthcare Ltd has informed BSE that the shareholders at the 13th Annual General Meeting (AGM) of the Company held on July 29, 2008, inter alia, have accorded to the following: 1. Adoption of Audited Balance Sheet as at March 31, 2008 and Profit and Loss Account of the Company for the year ended on that date and the Report of the Auditors and Directors, thereon together with Consolidated Balance Sheet as at March 31, 2008 and consolidated Profit and Account for the year ended or that date and the reports of the auditors thereon. 2. Declaration of dividend of Rs 4.50/- (Rupees Four and Paise Fifty Only) at the rate 90% per equity share, on equity shares of Rs 5/- each. 3. Re-appointment of Mr. Mukesh M Patel & Mr. Pranlal Bhogilal, as Directors of the Company, liable to retire by rotation. 4. Appointment of M/s. Mukesh M Shah & Co. Chartered Accountants, Ahmedabad, as a Statutory Auditors of the Company from the conclusion of this Annual General Meeting until the conclusion of the next Annual General Meeting of the Company, on remuneration, terms & conditions. 5. Payment of commission to the Non-Executive Directors of the Company (Other than the Managing Director, Deputy Managing Director and / or Whole Time Directors) to be determined by the Board of Directors for each Non-Executive Director for each financial year ending on March 31, 2009 upto and including financial year of the Company ending on March 31, 2013 to be calculated in accordance with the provisions of Section 349, 350 and 198 of the Companies Act, 1956 and distributed between such Directors in such a manner as the Board of Directors may from time to time determine within the maximum limit of one per cent of net profits of the Company, subject to maximum of Rs 10.00 million in addition to the sitting fees being paid by the Company for attending the Board / Committee Meetings of the Company. (As per BSE Announcement Website dated on 11/08/2008) 

EGM

22-Mar-10
Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 25, 2010, has taken the following decisions: 1. to increase the authorised share capital from existing Rs. 700/- Millions to Rs. 1100/- Millions and; 2. to issue bonus equity shares in the ratio of One equity share of Rs. 5/- each fully paid-up for every Two equity shares of Rs. 5/- each held by the shareholders of the Company on the Record Date to be fixed by the Board of Directors/Committee of the Board, subject to the approval of the shareholders and; 3. to convene Extra Ordinary General Meeting of shareholders on March 22, 2010 for the purpose. Cadila Healthcare Ltd has informed BSE that an Extra Ordinary General Meeting (EGM) of the members of the Company will be held on March 22, 2010, to transact the following business: 1. To increase the Authorised Share Capital of the Company from the existing Rs. 700,000,000/- (Rupees Seven Hundred Millions only) divided into 140,000,000 (One Hundred Forty Millions) Equity Shares of the face value of Rs.5/- (Rupees Five) each to Rs. 1,100,000,000/- (Rupees One Thousand One Hundred Millions only) divided into 220,000,000 (Two Hundred Twenty Millions) Equity Shares of the face value of Rs.5/- (Rupees Five) each and consequently alternation in the Memorandum of Association of the Company. 2. For capitalization of a sum not exceeding Rs. 341,247,535/- (Rupees Three Hundred Forty one Millions, Two Hundred and Forty seven Thousands, Five Hundred Thirty five only) from the Security Premium Account, General Reserves or any other permitted reserves / surplus of the Company for the purpose of issue of Bonus Shares of Rs. 5/- (Rupees Five only) each, credited as fully paid-up to the holders of Equity Shares of the Company whose names shall appear on the Register of Members on the Record Date determined by the Board or a Committee thereof for the purpose, in the proportion of 1(One) Bonus Share of Rs. 5/- each for every 2 (Two) fully paid-up Equity Shares of Rs. 5/- each held by them and that the Bonus Shares so distributed shall, for all purposes, be treated as an increase in the paid-up capital of the Company held by each such Member, and not as income; subject to necessary provisions & approvals. (As Per BSE Announcement Website dated on 02.03.2010) Cadila Healthcare Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on March 22, 2010, inter alia, have accorded to the following: 1. Increase the Authorised Share Capital of the Company from the existing Rs. 700,000,000/- (Rupees Seven Hundred Millions only) divided into 140,000,000 (One Hundred Forty Millions) Equity Shares of the face value of Rs.5/- (Rupees Five) each to Rs. 1,100,000,000/- (Rupees One Thousand One Hundred Millions only) divided into 220,000,000 (Two Hundred Twenty Millions) Equity Shares of the face value of Rs.5/- (Rupees Five) each and consequently alternation in the Memorandum of Association of the Company. 2. Authority to the Board for capitalization of a sum not exceeding Rs. 341,247,535/- (Rupees Three Hundred Forty one Millions, Two Hundred and Forty seven Thousands, Five Hundred Thirty five only) from the Security Premium Account, General Reserves or any other permitted reserves / surplus of the Company for the purpose of issue of Bonus Shares of Rs. 5/- (Rupees Five only) each, credited as fully paid-up to the holders of Equity Shares of the Company whose names shall appear on the Register of Members on the Record Date determined by the Board or a Committee thereof for the purpose, in the proportion of 1(One) Bonus Share of Rs. 5/- each for every 2 (Two) fully paid-up Equity Shares of Rs. 5/- each held by them and that the Bonus Shares so distributed shall, for all purposes, be treated as an increase in the paid-up capital of the Company held by each such Member, and not as income; subject to necessary provisions & approvals. (As Per BSE Announcement Website dated on 22.03.2010) 
18-Sep-08
Cadila Healthcare Ltd has informed BSE that the Company had filed a Company application with the Hon'ble High Court of Gujarat on August 11, 2008 for Composite Scheme of Arrangement between Carnation Nutra - Analogue Foods Ltd and Cadila Healthcare Ltd and Zydus Hospitals and Medical Research Pvt Ltd and their respective equity shareholders and creditors. Subsequently, the Hon'ble High Court of Gujarat, by an order made on August 13, 2008 has directed that a meeting of the Equity Shareholders and Unsecured Creditors of the Company be convened and held on September 18, 2008 for the purpose of considering, and if thought fit, approving with or without modification(s), the Composite Scheme of Arrangement between Carnation Nutra - Analogue Foods Ltd and Cadila Healthcare Ltd and Zydus Hospitals and Medical Research Pvt Ltd and their respective equity shareholders and creditors. Cadila Healthcare Ltd has informed BSE that the meeting of the Equity Shareholders and Unsecured Creditors of the Company as directed by the Hon'ble High Court of Gujarat at Ahmedabad was held on September 18, 2008. Mr. Mukesh M Patel, Chairman appointed for the meeting conducted the meeting as directed in the Minutes of Order of the Gujarat High Court dated August 13, 2008. The Composite Scheme of Arrangement between Carnation Nutra-Analogue Foods Ltd and Cadila Healthcare Ltd and Zydus Hospitals and Medical Research Pvt Ltd and their respective shareholders and creditors ("Composite Scheme") was approved by the requisite majority of the Equity Shareholders and by unanimous consent of Unsecured Creditors present and voting either in person or by proxy or as authorized representatives. The said Composite Scheme shall now be presented for approval and consideration of the Hon'ble High Court of Gujarat at Ahmedabad. (As per BSE Announcement dated on 23/09/2008) 
10-Mar-03
The company has informed that at the EGM held on 10.03.2003 the shareholders approved the Scheme of Amalgamation of German Remedies Ltd., Recon Healthcare Ltd., Zydus Pathline Ltd. and Zoom Properties Ltd. with the company with requisite majority.  

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Sun Pharma.Inds. 59,024.02 36.91 8.84 29.33 22.3 23.3 0.01
Dr Reddy's Labs 28,898.96 31.67 4.30 22.23 15.0 15.2 0.17
Cipla 24,889.90 22.14 3.32 18.79 15.4 17.9 0.04
Ranbaxy Labs. 22,222.51 17.79 11.55 0.00 0.0 0.0 1.22
Cadila Health. 15,284.86 23.25 6.00 21.79 32.9 27.5 0.31
Glenmark Pharma. 9,637.92 36.32 4.41 24.56 11.3 11.9 0.51
Wockhardt 8,617.31 29.96 71.71 39.85 0.0 0.0 3.18
Piramal Health 7,302.32 55.83 0.66 0.33 4.2 6.1 0.07
Torrent Pharma. 5,414.83 14.93 4.15 11.43 29.5 25.9 0.55
Biocon 4,322.00 16.91 2.06 11.21 26.2 26.8 0.10
Ipca Labs. 4,270.28 15.69 4.05 10.26 26.5 25.1 0.51
Strides Arcolab 3,982.81 61.55 2.94 16.20 5.1 5.7 0.97
Aurobindo Pharma 3,357.84 10.43 1.31 8.01 26.5 19.7 0.95
Matrix Labs. 3,273.19 8.13 2.00 0.00 28.9 27.4 0.52
Fres.Kabi Onco. 2,187.12 83.79 4.04 16.45 9.5 10.8 0.58

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

Pankaj R Patel , Chairman & Managing Director 

Sharvil P Patel , Deputy Managing Director 

Mukesh M Patel , Director 

H Dhanrajgir , Director 


Company Head Office / Quarters:
Zydus Tower,
Satellite Cross Roads,
Ahmedabad,
Gujarat-380015
Phone : 91-79-26868100
Fax : 91-79-26862366/5
E-mail : investor.grievance@zyduscadila.com
Web : http://www.zyduscadila.com
Registrars:
Sharepro Services India P Ltd
Samhita Complex
Plot No 13 AB
Saki Naka Andheri(E)
Mumbai-400072

Calendar

May-2012
M T W T F S S
21 22 23 24 25 26 27
IPO
listNo IPO today
Economic Events
list U. of Michigan Confidence
list Italian Hourly Wages (MoM)
Results
list Reliance Infra. | Crompton Greaves | ITC | Guj Fluorochem